Nicotine and Medical Research: The Overlooked Science Behind a Stigmatized Molecule

Nicotine has been vilified for decades, often conflated with the devastating health effects of smoking. Yet modern medical research continues to show that nicotine itself is not the cause of smoking-related cancers or cardiovascular disease. Instead, it is the combustion of tobacco, the burning process that releases thousands of toxic chemicals, that drives most smoking-related…

Policy Momentum on Nicotine Pouches in the UK: Balancing Regulation, Harm Reduction, and Youth Protection

Momentum is building in the United Kingdom toward a coherent and proportionate framework for regulating tobacco-free nicotine pouches. The Tobacco and Vapes Bill, currently progressing through Parliament, and the surrounding debates in both Houses have positioned the UK to establish a model that balances youth protection with adult harm reduction, consistent with NHS guidance and…

GINN’s Position on the EU Excise Directive Revision: Toward a Clear, Fair, and Evidence-Based Framework

GINN has formally contributed to the European Commission’s Consultation on the revision of Council Directive 2011/64/EU, which governs excise duties on tobacco and related products. We welcome the inclusion of nicotine pouches in this revision, provided they are recognized as a distinct, clearly defined category separate from traditional tobacco products. A science-based approach is essential.…

The Next Evolution of Alternative Nicotine: What Science and Innovation Reveal

The nicotine market is evolving faster than ever. Fueled by shifting consumer preferences, regulatory changes, and ongoing scientific advances, a new generation of smoke-free products is taking hold shape. As traditional tobacco declines, modern oral and inhalable formats are emerging as the next frontier for harm reduction, offering adult smokers safer, more convenient, and increasingly…